fluoxetine and semaglutide The Shortage Is Ending: What's Next For Compounded Drugs? Fluoxetine

I think bariatric surgery is underutilized

Is oral BPC 157 as effective as injectable

Graf MV, Schoenenberger, GA (1987)

Cost, supply chain challenges and regulatory issues mean that the full impact isnt going to be felt for years

Heres what the research shows for weight loss: Tirzepatide Results: Average weight loss: 15-21% of starting body weight Up to 65% of people lost 10% or more of their weight About 31% of people lost 20% or more of their weight Semaglutide Results: Average weight loss: 13-16% of starting body weight Around 73% of people lost 5% or more of their weight About 58% of people lost 10% or more of their weight Real-World Results In real-world clinical settings, people taking tirzepatide were more likely to achieve significant weight loss milestones compared to those taking semaglutide